Abstract | BACKGROUND: METHODS AND RESULTS: Two hundred patients (61+/-10 year-old, male 143) diagnosed with UAP at an emergency medical center were randomly assigned to 2 groups: intravenous isosorbide dinitrate, Group I (n=100), or intravenous nicorandil, Group II (n=100). PCI was performed 12-48 h after infusion of each agent. Serum concentrations of creatine kinase-MB (CK-MB), cardiac troponin T (cTnT), and I (cTnI) were measured before and 6, 12, 24 h after PCI. Patients with non-coronary chest pain, requiring emergency coronary angiogram, temporary pacemaker or glycoprotein IIb/IIIa receptor blocker were excluded. PCI was successfully performed in 96 patients (Group I=54, 61.7+/-8.2 years, 32 males; Group II=42, 60.4+/-11.7 years, 27 males). No significant differences in clinical or coronary angiographic characteristics were observed between the 2 groups. The concentration of CK-MB was elevated in 9 patients (17%) of Group I and 6 (14%) of Group II, cTnT in 16 (30%), 6 (14%) and cTnI in 25 (46%), 9 (21%) after PCI. Elevation of any troponin was less frequent in Group II [28/54 (52%) vs 10/42 (24%) patients, p=0.01]. Major adverse coronary events during the 6-month clinical follow-up occurred in 9 (17%) of Group I and 5 patients of Group II (12%, p=NS). Follow-up echocardiography revealed lower left ventricular ejection fraction in Group I than in Group II (65.4+/-7.2% vs 71.0+/-6.7%, p=0.03). CONCLUSION:
Nicorandil has a myocardial protective effect during PCI in patients with UAP.
|
Authors | Ju Han Kim, Myung Ho Jeong, Kyung Ho Yun, Kye Hun Kim, Dong Koo Kang, Seo Na Hong, Sang Yup Lim, Sang Hyun Lee, Yun Sang Lee, Young Joon Hong, Hyung Wook Park, Weon Kim, Young Keun Ahn, Jeong Gwang Cho, Jong Chun Park, Jung Chaee Kang |
Journal | Circulation journal : official journal of the Japanese Circulation Society
(Circ J)
Vol. 69
Issue 3
Pg. 306-10
(Mar 2005)
ISSN: 1346-9843 [Print] Japan |
PMID | 15731536
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Biomarkers
- Cardiotonic Agents
- Nicorandil
- Isosorbide Dinitrate
|
Topics |
- Aged
- Angina Pectoris
(drug therapy, surgery)
- Angiography
- Angioplasty, Balloon, Coronary
(methods)
- Biomarkers
(blood)
- Cardiotonic Agents
(administration & dosage)
- Echocardiography
- Female
- Humans
- Isosorbide Dinitrate
(administration & dosage)
- Male
- Middle Aged
- Nicorandil
(administration & dosage)
- Stroke Volume
- Treatment Outcome
|